MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A3263 BRAF inhibitorSummary: Potent B-raf inhibitor
-
A3264 B-Raf inhibitorSummary: A B-Raf inhibitor
-
A3297 CEP-32496 hydrochlorideSummary: B-Raf/C-Raf inhibitor,highly potent
-
A3347 Dabrafenib Mesylate (GSK-2118436)Target: RafSummary: Inhibitor of BRAF(V600) mutants
-
A3627 MLN 2480Summary: Pan-Raf kinase inhibitor,investigational
-
B1172 B-Raf inhibitor 1Summary: Potent and selective B-Raf inhibitor
-
B1173 B-Raf inhibitor 1 dihydrochlorideSummary: B-Raf inhibitor,potent and selective
-
B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
-
B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective
-
A8371 AZ 628Summary: Raf kinases,potent and ATP-competitive